Thursday, November 29, 2007

Biotech meets demography meets (as always) finance

Brandon Kein initiates the discussion about the possible costs of future life-extending therapies. Add to that the grim outlook of fiscal and pension systems even assuming no revolutionary breakthroughs in biotech, and you have the recipe for interesting times ahead.

No comments: